Heriansyah, T.; Nur Chomsy, I.; Febrianda, L.; Farahiya Hadi, T.; Andri Wihastuti, T.
The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review. Sci. Pharm. 2020, 88, 55.
https://doi.org/10.3390/scipharm88040055
AMA Style
Heriansyah T, Nur Chomsy I, Febrianda L, Farahiya Hadi T, Andri Wihastuti T.
The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review. Scientia Pharmaceutica. 2020; 88(4):55.
https://doi.org/10.3390/scipharm88040055
Chicago/Turabian Style
Heriansyah, Teuku, Indah Nur Chomsy, Lyra Febrianda, Tjut Farahiya Hadi, and Titin Andri Wihastuti.
2020. "The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review" Scientia Pharmaceutica 88, no. 4: 55.
https://doi.org/10.3390/scipharm88040055
APA Style
Heriansyah, T., Nur Chomsy, I., Febrianda, L., Farahiya Hadi, T., & Andri Wihastuti, T.
(2020). The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review. Scientia Pharmaceutica, 88(4), 55.
https://doi.org/10.3390/scipharm88040055